AN2 Therapeutics, Inc. (ANTX): 424B5 filed Apr 20, 2026

Form type

424B5

Filing date

Apr 20, 2026

Accession number

0001193125-26-164095

Filer

AN2 Therapeutics, Inc. (CIK 1880438)